Stock 6896 GOLDEN THROAT HOLDINGS GROUP COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Golden Throat Holdings Group Company Limited

Equities

6896

KYG3961J1022

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:20 26/04/2024 BST 		5-day change 1st Jan Change
3.75 HKD +0.27% Intraday chart for Golden Throat Holdings Group Company Limited +1.63% +11.94%
03-27 Golden Throat Holdings Group Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 26 June 2024 CI
03-27 Golden Throat Holdings Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 1,195 818 786.2 827.6 951.8 1,247
Enterprise Value (EV) 1 670.3 279.8 305 274.5 383.9 594.2
P/E ratio 19.5 x 8 x 4.69 x 5.37 x 5.07 x 4.43 x
Yield 6.18% 9.53% 10.1% 4.51% 11.4% 18.9%
Capitalization / Revenue 1.91 x 1.18 x 0.99 x 1.28 x 1.16 x 1.26 x
EV / Revenue 1.07 x 0.4 x 0.38 x 0.42 x 0.47 x 0.6 x
EV / EBITDA 8.44 x 1.7 x 1.4 x 1.64 x 1.56 x 1.49 x
EV / FCF -18 x -50.2 x 9.74 x 3.43 x -13.6 x 4.79 x
FCF Yield -5.54% -1.99% 10.3% 29.1% -7.33% 20.9%
Price to Book 1.26 x 0.77 x 0.68 x 0.68 x 0.7 x 0.81 x
Nbr of stocks (in thousands) 739,302 739,302 739,302 739,302 739,302 739,302
Reference price 2 1.616 1.106 1.063 1.119 1.287 1.687
Announcement Date 16/04/18 29/04/19 24/04/20 23/04/21 21/04/22 26/04/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 624.1 694.2 797.1 646.9 820.5 992
EBITDA 1 79.42 164.4 218.2 167 246.1 398
EBIT 1 73.2 159.1 212.5 138.8 212.9 363.3
Operating Margin 11.73% 22.92% 26.65% 21.46% 25.95% 36.62%
Earnings before Tax (EBT) 1 94.2 149.5 219.9 189.9 236.8 376
Net income 1 61.38 102.2 167.6 154.1 187.6 281.2
Net margin 9.84% 14.72% 21.03% 23.81% 22.87% 28.35%
EPS 2 0.0830 0.1382 0.2267 0.2084 0.2538 0.3804
Free Cash Flow 1 -37.16 -5.57 31.33 80.01 -28.14 124.2
FCF margin -5.95% -0.8% 3.93% 12.37% -3.43% 12.52%
FCF Conversion (EBITDA) - - 14.36% 47.92% - 31.19%
FCF Conversion (Net income) - - 18.69% 51.94% - 44.15%
Dividend per Share 2 0.0999 0.1054 0.1073 0.0505 0.1466 0.3184
Announcement Date 16/04/18 29/04/19 24/04/20 23/04/21 21/04/22 26/04/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 524 538 481 553 568 653
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -37.2 -5.57 31.3 80 -28.1 124
ROE (net income / shareholders' equity) 6.36% 10.2% 15.2% 13% 14.5% 19.4%
ROA (Net income/ Total Assets) 3.27% 6.98% 8.53% 5.24% 7.32% 10.7%
Assets 1 1,875 1,463 1,965 2,941 2,565 2,633
Book Value Per Share 2 1.280 1.430 1.560 1.650 1.850 2.080
Cash Flow per Share 2 0.8300 0.8600 0.7800 0.9500 0.9800 1.210
Capex 1 87.6 122 129 83.9 48.7 15.8
Capex / Sales 14.04% 17.54% 16.23% 12.98% 5.93% 1.6%
Announcement Date 16/04/18 29/04/19 24/04/20 23/04/21 21/04/22 26/04/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
GOLDEN THROAT HOLDINGS GROUP COMPANY LIMITED Stock Golden Throat Holdings Group Company Limited
+11.94% 354M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.62% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+10.86% 14.09B
CIPLA LIMITED Stock Cipla Limited
+13.07% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.46% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 6896 Stock
  4. Financials Golden Throat Holdings Group Company Limited